Amphastar Pharmaceuticals Inc [AMPH] stock prices are up 3.98% to $27.16 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AMPH shares have gain 7.52% over the last week, with a monthly amount glided 15.53%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on August 12, 2025, when Needham upgraded its rating to a Buy but kept the price target unchanged to $36 for it. Previously, JP Morgan downgraded its rating to Neutral on May 12, 2025, and kept the price target unchanged to $30. On February 04, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $36 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $55 on November 22, 2024. JP Morgan initiated its recommendation with a Overweight and recommended $60 as its price target on March 05, 2024. BofA Securities started tracking with a Neutral rating for this stock on November 17, 2023, and assigned it a price target of $63.
The stock price of Amphastar Pharmaceuticals Inc [AMPH] has been fluctuating between $20.39 and $49.17 over the past year. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $27.16 at the most recent close of the market. An investor can expect a potential return of 17.82% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
The Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] reported sales of 723.30M for trailing twelve months, representing a surge of 0.33%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.15 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.37 points at the first support level, and at 25.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.58, and for the 2nd resistance point, it is at 28.00.
Ratios To Look Out For
It’s worth pointing out that Amphastar Pharmaceuticals Inc [NASDAQ:AMPH]’s Current Ratio is 3.12. In addition, the Quick Ratio stands at 2.21 and the Cash Ratio stands at 1.05. Considering the valuation of this stock, the price to sales ratio is 1.73, the price to book ratio is 1.62 and price to earnings (TTM) ratio is 12.04.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on Nov 03 ’25 when 500.0 shares were sold. Director, Petersen Floyd F. completed a deal on Nov 03 ’25 to buy 500.0 shares. Meanwhile, Director Petersen Floyd F. sold 500.0 shares on Oct 01 ’25.
